Efficacy of pneumococcal conjugate vaccine in preventing acquisition and carriage of pneumococcal vaccine serotypes in Tanzanian children with human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS)

Not Applicable

• Conditions: Pneumococcal disease; HIV/AIDS; Public Health - Epidemiology; Infection - Studies of infection and infectious agents

• Registration Number: ACTRN12610000999033
• Lead Sponsor: Prof Robert Booy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-11-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 216

Inclusion Criteria

HIV positive children aged 1-14 years old

Exclusion Criteria

Previous vaccination

Study & Design

• Study Type: Interventional
• Study Design: Not specified